Variant report
Variant | nsv516004 |
---|---|
Chromosome Location | chr21:45988426-45989211 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:28)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:28 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr21:45989043-45989370 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr21:45988860-45989389 | K562 | blood: | n/a | chr21:45988914-45988930 |
3 | CBX3 | chr21:45989101-45989409 | K562 | blood: | n/a | n/a |
4 | CBX3 | chr21:45989069-45989379 | K562 | blood: | n/a | n/a |
5 | CREB1 | chr21:45989022-45989466 | K562 | blood: | n/a | n/a |
6 | CTCF | chr21:45988725-45988832 | MCF-7 | breast: | n/a | n/a |
7 | CTCF | chr21:45988758-45988778 | MCF-7 | breast: | n/a | n/a |
8 | E2F6 | chr21:45988776-45989340 | K562 | blood: | n/a | n/a |
9 | E2F6 | chr21:45988390-45988519 | K562 | blood: | n/a | n/a |
10 | E2F6 | chr21:45988802-45989066 | K562 | blood: | n/a | n/a |
11 | E2F6 | chr21:45989068-45989270 | K562 | blood: | n/a | n/a |
12 | EP300 | chr21:45989208-45989329 | K562 | blood: | n/a | n/a |
13 | GABPA | chr21:45988798-45989418 | K562 | blood: | n/a | chr21:45988904-45988913 |
14 | GABPA | chr21:45989003-45989451 | K562 | blood: | n/a | n/a |
15 | HMGN3 | chr21:45989193-45989382 | K562 | blood: | n/a | n/a |
16 | MAX | chr21:45988722-45989381 | K562 | blood: | n/a | chr21:45988997-45989006 chr21:45988916-45988923 chr21:45988998-45989005 chr21:45988801-45988810 chr21:45988799-45988808 chr21:45988915-45988924 chr21:45988802-45988809 |
17 | MAX | chr21:45988792-45989371 | K562 | blood: | n/a | chr21:45988997-45989006 chr21:45988916-45988923 chr21:45988998-45989005 chr21:45988801-45988810 chr21:45988799-45988808 chr21:45988915-45988924 chr21:45988802-45988809 |
18 | MAX | chr21:45988799-45989040 | K562 | blood: | n/a | chr21:45988997-45989006 chr21:45988916-45988923 chr21:45988998-45989005 chr21:45988801-45988810 chr21:45988799-45988808 chr21:45988915-45988924 chr21:45988802-45988809 |
19 | MAX | chr21:45989059-45989305 | K562 | blood: | n/a | n/a |
20 | MAX | chr21:45988802-45989060 | NB4 | blood: | n/a | chr21:45988997-45989006 chr21:45988916-45988923 chr21:45988998-45989005 chr21:45988915-45988924 chr21:45988802-45988809 |
21 | MYC | chr21:45988902-45989377 | K562 | blood: | n/a | chr21:45988997-45989006 chr21:45988916-45988923 chr21:45988998-45989005 chr21:45988915-45988924 |
22 | MYC | chr21:45989095-45989304 | K562 | blood: | n/a | n/a |
23 | POLR2A | chr21:45988990-45988996 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr21:45988978-45988988 | MCF-7 | breast: | n/a | n/a |
25 | POLR2A | chr21:45989027-45989029 | MCF-7 | breast: | n/a | n/a |
26 | POLR2A | chr21:45989000-45989026 | MCF-7 | breast: | n/a | n/a |
27 | RCOR1 | chr21:45989115-45989265 | K562 | blood: | n/a | n/a |
28 | USF1 | chr21:45989008-45989331 | K562 | blood: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:45987563..45989403-chr21:45990992..45992920,2 | MCF-7 | breast: | |
2 | chr21:45971316..45974046-chr21:45988116..45989981,2 | MCF-7 | breast: | |
3 | chr21:45979063..45980801-chr21:45987415..45990235,2 | MCF-7 | breast: | |
4 | chr21:45987378..45989214-chr21:45998869..46000795,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRTAP10-4 | TF binding region |
ENSG00000205445 | chromatin interactions |
ENSG00000241123 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12627324 | chr21:45988426-45988427 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs587594164 | chr21:45988525-45988526 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs138833721 | chr21:45988536-45988537 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs587663846 | chr21:45988552-45988553 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs461436 | chr21:45988559-45988560 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs184239397 | chr21:45988580-45988581 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs141362755 | chr21:45988611-45988612 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs587685561 | chr21:45988649-45988650 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs9982654 | chr21:45988669-45988670 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs587624927 | chr21:45988691-45988692 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs456780 | chr21:45988710-45988711 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs142037012 | chr21:45988735-45988736 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs145719403 | chr21:45988778-45988779 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs375292859 | chr21:45988820-45988821 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs369889759 | chr21:45988856-45988857 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs9982855 | chr21:45988863-45988864 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs587733848 | chr21:45988888-45988889 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs9983521 | chr21:45988906-45988907 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs587630976 | chr21:45988907-45988908 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs587714805 | chr21:45988908-45988909 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs138401446 | chr21:45988919-45988920 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs201882096 | chr21:45988994-45988995 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs149604892 | chr21:45988997-45988998 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers ZNF genes & repeats | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs587710166 | chr21:45989002-45989003 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs587607841 | chr21:45989008-45989009 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs17004672 | chr21:45989026-45989027 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs465079 | chr21:45989035-45989036 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs587632171 | chr21:45989081-45989082 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs587657620 | chr21:45989095-45989096 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs457647 | chr21:45989115-45989116 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs587616789 | chr21:45989120-45989121 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs587721656 | chr21:45989127-45989128 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs12627518 | chr21:45989128-45989129 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs587645977 | chr21:45989146-45989147 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs117381890 | chr21:45989149-45989150 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs457692 | chr21:45989158-45989159 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs587636345 | chr21:45989159-45989160 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs587714024 | chr21:45989170-45989171 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs144347950 | chr21:45989183-45989184 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs457697 | chr21:45989191-45989192 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs373126212 | chr21:45989197-45989198 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs587708366 | chr21:45989207-45989208 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs457698 | chr21:45989211-45989212 | Weak transcription Genic enhancers Bivalent Enhancer Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:45978400-45994400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr21:45987000-45989600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr21:45987800-45989400 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr21:45988200-45989400 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr21:45988200-45989800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
6 | chr21:45988400-45988800 | Weak transcription | Gastric | stomach |
7 | chr21:45988800-45989000 | ZNF genes & repeats | Gastric | stomach |
8 | chr21:45989000-45994200 | Weak transcription | Gastric | stomach |